Arbor Biotechnologies

Provider of genomic technologies and drug discovery platform

placeCambridge, Massachusetts, United States calendar_todayFounded 2016 groups117 employees language arbor.bio

Registered entities

Social engagement

Social engagement: 16.5K social following, 9 posts in the last 12 months — around the industry typical range.

Investor mix

29 investors on record; lead investors include Temasek, TCG Crossover, Arch Venture Partners, Ally Bridge Group.

Investor typeCountShare
Venture capital1241%
Private equity414%
Accelerator & incubator13%
Bank & private debt27%
Other / undisclosed1034%

Recent activity

29 Jun 2026
Partnership
Department of Health Abu Dhabi
26 Jun 2026
Milestone
regulatory
22 Jun 2026
Partnership
Chiesi Global Rare Diseases
Coming soon